← back to search

Jesse T. Jacob

Emory University · US
🔎 Find collaborators in Molecular Medicine · Applied Microbiology and Biotechnology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Medicine · Applied Microbiology and Biotechnology
Research interest
Research interests include Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Bacterial Identification and Susceptibility Testing, and Antibiotics Pharmacokinetics and Efficacy.
h-index
39
citations
6,714
works
282
NIH funding
primary concept
Medicine
email

Recent publications

Transmission pathways during high-contact care activities in nursing homes: a high-fidelity simulation study with surrogate markers.
2026cited by 0position: contributordoi
Society for Healthcare Epidemiology of America supports environmental stewardship and sustainability while protecting patients and healthcare personnel position statement of the SHEA Board.
2026cited by 0position: contributordoi
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
2026cited by 0position: contributordoi
Estimating the likelihood of hospitalists to repeatedly prescribe high rates of antibiotics.
2025cited by 1position: contributordoi
Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance.
2025cited by 0position: contributordoi
Electronic Health Record Design Impacts Clinician Ordering Behavior: An Interrupted Time Series Analysis.
2025cited by 0position: contributordoi
Identifying patients at high risk for carbapenem-resistant Enterobacterales (CRE) carriage on admission to acute care hospitals: validating and expanding on a public health model.
2025cited by 0position: contributordoi
An Observational Study to Determine the Prevalence of COVID-19 Among Hospitalized Patients With Multidrug-Resistant Enterobacterales Infections and Clinical Outcomes, 10 US Sites, 2020--2022.
2025cited by 0position: contributordoi
Early Tecovirimat Treatment for Mpox Disease Among People With HIV
JAMA Internal Medicine 2024cited by 30position: middledoi
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study
BMJ Quality & Safety 2024cited by 19position: middledoi
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.
2024cited by 16position: contributordoi
Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant Enterobacterales.
2024cited by 12position: contributordoi
Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
2024cited by 4position: contributordoi
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales.
2024cited by 4position: contributordoi
Implementing nasal povidone-iodine decolonization to reduce infections in hemodialysis units: a qualitative assessment
Infection Control and Hospital Epidemiology 2024cited by 3position: middledoi
The role of the hospital bed in hospital-onset <i>Clostridioides difficile</i>: A retrospective study with mediation analysis.
2024cited by 3position: contributordoi
Derivation of a risk-adjusted model to predict antibiotic prescribing among hospitalists in an academic healthcare network.
2024cited by 2position: contributordoi
A high prevalence of antibiotic use at two large teaching hospitals in Addis Ababa, Ethiopia: a point prevalence survey.
2024cited by 2position: contributordoi
Effect of an initial specimen diversion device on blood-culture contamination rates and vancomycin usage: A quasi-experimental study.
2024cited by 2position: contributordoi
Implementing nasal povidone-iodine decolonization to reduce infections in hemodialysis units: a qualitative assessment.
2024cited by 2position: contributordoi
Evaluating indwelling devices and other risk factors for mortality in invasive Carbapenem-resistant Enterobacterales infections in Georgia, 2012-2019.
2024cited by 0position: contributordoi
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant <i>Acinetobacter baumannii</i> Among Patients From Different Global Regions
Clinical Infectious Diseases 2023cited by 88position: middledoi
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review.
2023cited by 36position: contributordoi
Associations Between HIV and Severe Mpox in an Atlanta Cohort
The Journal of Infectious Diseases 2023cited by 33position: middledoi
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020
Open Forum Infectious Diseases 2023cited by 23position: middledoi
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.
2023cited by 23position: contributordoi
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020.
2023cited by 21position: contributordoi
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites.
2023cited by 6position: contributordoi
Outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in hospitalized hemodialysis patients: An epidemiologic and genomic investigation.
2023cited by 4position: contributordoi
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
2022cited by 261position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 39 papers (2019–2026)David S. Weiss · Carl von Ossietzky Universität Oldenburg15 papers (2018–2022)Ghinwa Dumyati · University of Rochester Medical Center13 papers (2015–2025)Susan M. Ray · Emory University9 papers (2019–2022)Jessica Howard-Anderson · Emory University9 papers (2021–2025)Scott K. Fridkin · Emory University9 papers (2013–2025)Sarah W. Satola · Emory University8 papers (2018–2024)David van Duin · University of North Carolina at Chapel Hill7 papers (2021–2024)Yohei Doi · University of Pittsburgh7 papers (2020–2024)Zanthia Wiley · Emory University6 papers (2019–2024)James P. Steinberg · Emory University Hospital Midtown6 papers (2012–2021)Eileen M. Burd · Emory University6 papers (2014–2021)Anthony D. Harris · Institute of Computing Technology6 papers (2015–2022)Lucy Wilson · Maryland Department of Health5 papers (2015–2023)Joseph D. Lutgring · Centers for Disease Control and Prevention5 papers (2021–2023)Ahmed Babiker · National Center for Infectious Diseases5 papers (2021–2024) · 5 papers (2021–2024) · 5 papers (2021–2025)Ruth Lynfield · Minnesota Department of Health5 papers (2013–2023)Colleen S. Kraft · Emory University5 papers (2014–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Medicine · Applied Microbiology and Biotechnology →